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Background: Unicuspid aortic valve (UAV) is a rare congenital malformation observed in 0.02% of pop-
ulation1. It shares several characteristics with bicuspid aortic valve (BAV), such as premature valvular 
calcification and aortic root dilatation which occur more rapidly in UAV. UAV most often presents with 
aortic stenosis (AS), either isolated or concomitant with aortic regurgitation2.
Case report: 47-year-old female was diagnosed with BAV and AS at the age of four. She underwent 
regular echocardiographic follow-ups and was asymptomatic, which was regularly confirmed with 
stress tests. She had two uncomplicated pregnancies and one miscarriage. In 2019, stress echocar-
diography showed good functional capacity and preserved left ventricular (LV) function, with good 
improvement in LV ejection fraction (LVEF) and global longitudinal strain (GLS) during exercise, nor-
mal NT-proBNP, but increase in mean pressure gradient (PG) during work-up for >20 mmHg (Figure 1). 
Closely follow-up was indicated. In January 2021 she had anaphylactic reaction after food intake. After 
that event she started to complain of frequent light-headedness and palpitations on effort, without 
syncope. She underwent thorough neurological and ear, nose and throat evaluation including brain 
magnetic resonance imaging, and no pathology was found. Laboratory findings showed elevated NT-
proBNP of 400 ng/L. She was admitted to resolve if the symptoms were truly due to AS. Transthoracic 
and transesophageal echocardiography (Figure 2) demonstrated a LVEF of 60%, GLS -22% and UAV 
with severe AS (max PG 80 mmHg, mean PG 51 mmHg, AVA VTI 0.58 cm2). MSCT aortography showed 
slightly dilated ascending aorta, diameter 4,2 cm. On 24-hour ECG recording, nonsustained ventricular 
tachycardias originating from LV were recorded and correlated with symptoms. Due to arrythmias 
caused by pressure overloaded LV, elevation in NT-proBNP and clinical correlation, aortic valve re-
placement was indicated. 
Discussion: UAV with AS is rare congenital malformation usually diagnosed in childhood but may 
advance into adulthood before becoming symptomatic. Echocardiography is a key tool in confirming 
presence and assessment of severity of AS. Additional value of stress echocardiography is in revealing 
symptoms or proving truly asymptomatic AS, which is of most importance for timing of surgery. We 
Figure 1. Stress echocardiography at baseline (A) and at 130 W (B) showing normal response in 
improvement in left ventricular ejection fraction (LVeF) and global longitudinal strain (gLS). The aortic 
valve area (AVA) remained unchanged, with increase in the mean pressure gradient (Pg) of 24mmHg. 
The patient was asymptomatic during the test. 
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Figure 2. 3D transesophageal echocardiography reconstruction for measurement of the 3D aortic valve area (AVA) by planime-
try (A).  unicuspid aortic valve shown in TOe X-plane, arrow pointing at single commissural zone of attachment and eccentric 
valvular orifice during systole (B). Transthoracic measurement of peak velocity across the aortic valve (C). 
presented a case of UAV with long asymptomatic phase of the disease. Asymptomatic patients should be re-evaluated every six 
months for the occurrence of symptoms and change in echocardiographic parameters3.
Conclusion: In every case of severe AS, no matter of valve morphology, close clinical and echo follow up, including stress test is 
crucial in deciding on right timing for intervention. 
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